PEDIATRICS Vol. 99 No. 4 April 1997, pp. e9 (doi:10.1542/peds.99.4.e9)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robin, L. F.
Right arrow Articles by Middaugh, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robin, L. F.
Right arrow Articles by Middaugh, J. P.
Related Collections
Right arrow Therapeutics & Toxicology

PEDIATRICS Vol. 99 No. 4 April 1997, p. e9
Copyright ©1997 by the American Academy of Pediatrics

ELECTRONIC ARTICLE:
Statewide Assessment of Lead Poisoning and Exposure Risk Among Children Receiving Medicaid Services in Alaska

Received May 29, 1996; accepted Sept 4, 1996.

Laura F. Robin*, Michael BellerDagger , and John P. MiddaughDagger

From the * Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia; and the Dagger  Section of Epidemiology, Alaska Department of Health and Social Services, Anchorage, Alaska.

Objective.  Lead poisoning is a well-recognized public health concern for children living in the United States. In 1992, Health Care Financing Administration (HCFA) regulations required lead poisoning risk assessment and blood lead testing for all Medicaid-enrolled children ages 6 months to 6 years. This study estimated the prevalence of blood lead levels (BLLs) >= 10 µg/dL (>= 0.48 µmol/L) and the performance of risk assessment questions among children receiving Medicaid services in Alaska.

Design.  Measurement of venous BLLs in a statewide sample of children and risk assessment using a questionnaire modified from HCFA sample questions.

Setting.  Eight urban areas and 25 rural villages throughout Alaska.

Patients.  Nine hundred sixty-seven children enrolled in Medicaid, representing a 6% sample of 6-month- to 6-year-old Alaska children enrolled in Medicaid.

Outcome Measure(s).  Determination of BLL and responses to verbal-risk assessment questions.

Results.  BLLs ranged from <1 µg/dL (<0.048 µmol/L) to 21 µg/dL (1.01 µmol/L) (median, 2.0 µg/dL or 0.096 µmol/L). The geometric mean BLLs for rural and urban children were 2.2 µg/dL (0.106 µmol/L) and 1.5 µg/dL (0.072 µmol/L), respectively. Six (0.6%) children had a BLL >= 10 µg/dL; only one child had a BLL >= 10 µg/dL (11 µg/dL or 0.53 µmol/L) on retesting. Children whose parents responded positively to at least one risk factor question were more likely to have a BLL >= 10 µg/dL (prevalence ratio = 3.1; 95% confidence interval = 0.4 to 26.6); the predictive value of a positive response was <1%.

Conclusions.  In this population, the prevalence of lead exposure was very low (0.6%); only one child tested (0.1%) maintained a BLL >= 10 µg/dL on confirmatory testing; no children were identified who needed individual medical or environmental management for lead exposure. Universal lead screening for Medicaid-enrolled children is not an effective use of public health resources in Alaska. Our findings identify an example of the importance in considering local and regional differences when formulating screening recommendations and regulations, and continually reevaluating the usefulness of federal regulations. lead poisoning, child health services, mass screening, government regulations, Medicaid.